(Q43824309)

27 November 2017

title

Urinary calcium excretion in the monitoring of bone metastases from prostatic carcinoma. (English)

1 reference

27 November 2017

4

1 reference

27 November 2017

Francini G

1

1 reference

27 November 2017

Petrioli R

2

1 reference

27 November 2017

Gonnelli S

3

1 reference

27 November 2017

Pozzessere D

5

1 reference

27 November 2017

Marsili S

6

1 reference

27 November 2017

Montagnani A

7

1 reference

27 November 2017

Lucani B

8

1 reference

27 November 2017

Rossi S

9

1 reference

27 November 2017

Monaco R

10

1 reference

27 November 2017

Manganelli A

11

1 reference

27 November 2017

Salvestrini F

12

1 reference

27 November 2017

Fiaschi AI

13

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

92

1 reference

27 November 2017

issue

6

1 reference

27 November 2017

page(s)

1468-1474

1 reference

Weekly chemotherapy in advanced prostatic cancer

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Chemotherapy with mitoxantrone plus prednisone or prednisone alone for symptomatic hormone-resistant prostate cancer: a Canadian randomized trial with palliative end points.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Prostate specific antigen in hormonally treated stage D2 prostate cancer: is it always an accurate indicator of disease status?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Biochemical markers of bone metabolism: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Coupling of bone formation to bone resorption: a broader view

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Tetracycline-based histological analysis of bone remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

The meaning and use of the area under a receiver operating characteristic (ROC) curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

A method of comparing the areas under receiver operating characteristic curves derived from the same cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

The Measurement of Observer Agreement for Categorical Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Statistical methods for assessing agreement between two methods of clinical measurement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Biochemical markers for the detection of bone metastasis in patients with prostate cancer: diagnostic efficacy and the effect of hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Assessment of response to therapy in advanced breast cancer: a project of the Programme on Clinical Oncology of the International Union Against Cancer, Geneva, Switzerland

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Monitoring of bone metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Prostate specific antigen and bone scan correlation in the staging and monitoring of patients with prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Correlation between bone metabolic markers and bone scan in prostatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Prostate-specific antigen as a measure of disease outcome in metastatic hormone-refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Morphometric evidence for bone resorption and replacement in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

The measurement and the meaning of urinary calcium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Treatment of bone metastases with dichloromethylene bisphosphonate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

New and traditional serum markers of bone metabolism in the detection of skeletal metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Use of bone turnover marker, pyridinoline cross-linked carboxyterminal telopeptide of type I collagen (ICTP), in the assessment and monitoring of bone metastasis in prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2820010915%2992%3A6%3C1468%3A%3AAID-CNCR1471%3E3.0.CO%3B2-S

10.1002/1097-0142(20010915)92:6<1468::AID-CNCR1471>3.0.CO;2-S

21 January 2018

Identifiers

DOI

1 reference

27 November 2017

1 reference